A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

Eurolab has achieved a landmark legal victory in South Africa, allowing the company to produce and sell a generic version of ...

Mateship, support, information: this and more are what two cancer survivors are hopeful a dedicated prostate cancer nurse can ...

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ...

Prostate cancer is a serious health problem for men around the world. Doctors know that things like being overweight, having ...

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

The WOLVERINE study analyzed five trials and found metastasis-directed therapy -- primarily radiation -- may delay castration resistance and improve other long-term outcomes in prostate cancer. While ...

Currently, doctors usually check PSA levels about six to eight weeks after surgery. However, a new study from Mass General ...

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...

Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...